Literature DB >> 22565229

Psychiatric systems medicine: closer at hand than anticipated but not with the expected portrait.

F Iris1.   

Abstract

Almost all complex human diseases are context-dependent entities to which molecular components make a necessary, but only partial, contribution. This is particularly evident in psychiatric conditions such as schizophrenia and major depressive disorders. Here, classical analytical approaches based on reductionism lead to profound misconceptions of the actual nature of the problem. Consequently, a systems perspective may be the optimal method for approaching complex psychiatric diseases. However, attempting to productively apply systems principles to complex medical conditions is much more difficult than hitherto anticipated. Living systems are integrative and non-linear by nature and embody higher level functional principles that are not reducible to the molecular level. Furthermore, whereas systems biology functions on the basis of large data sets arising from highly targeted investigations upon homogeneous experimental material, systems medicine must proceed on the basis of existing, highly heterogeneous data. The challenge is therefore to assimilate a large, and often conflicting corpus of data to build and inform a systems-level model of the physiological alterations underlying the disorders while reaching beyond somatism (bottom-up approaches), which is provably largely insufficient to functionally explain multicellular living systems to a degree enabling informed therapeutic intervention. This paper factually documents how a modelling approach based on a combination of heuristics (top-down) and algorithmic (bottom-up) modelling strategies, together with the active participation of clinician networks can provide an effective roadmap to productively address psychiatric disorders at large, and schizophrenia in particular. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22565229     DOI: 10.1055/s-0032-1309002

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  5 in total

Review 1.  Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.

Authors:  Mark J Niciu; Daniel C Mathews; Allison C Nugent; Dawn F Ionescu; Maura L Furey; Erica M Richards; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2013-12-18       Impact factor: 6.505

2.  Biomarkers in mood disorders research: developing new and improved therapeutics.

Authors:  Mark J Niciu; Daniel C Mathews; Dawn F Ionescu; Erica M Richards; Maura L Furey; Peixiong Yuan; Allison C Nugent; Ioline D Henter; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Rev Psiquiatr Clin       Date:  2014       Impact factor: 0.909

Review 3.  A new mechanistic approach for the treatment of chronic neuropathic pain with nitrous oxide integrated from a systems biology narrative review.

Authors:  Baptiste Bessiere; François Iris; Aude Milet; Athanasios Beopoulos; Catherine Billoet; Géraldine Farjot
Journal:  Med Gas Res       Date:  2021 Jan-Mar

4.  Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome-Host Interaction Mechanistic Hypothesis.

Authors:  Athanasios Beopoulos; Manuel Gea; Alessio Fasano; François Iris
Journal:  Nutrients       Date:  2021-12-24       Impact factor: 5.717

Review 5.  Maternal malnutrition and anaemia in India: dysregulations leading to the 'thin-fat' phenotype in newborns.

Authors:  Prachi Pandit; Sanjeev Galande; François Iris
Journal:  J Nutr Sci       Date:  2021-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.